Table: Garna Biosciences -Q1 group results

Carna Biosciences

13/05/2019 07:30

May 13 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2019        Mar 31, 2018       Dec 31, 2019  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            169 mln             211 mln             1.24      
                 (-19.5 pct)         (+7.7 pct)        (+64.3 pct)   
  Operating     loss 233 mln        loss 188 mln        loss 1.66    
  Recurring     loss 235 mln        loss 191 mln        loss 1.67    
  Net           loss 236 mln        loss 194 mln        loss 1.69    
  EPS          loss 23.16 yen      loss 20.36 yen    loss 166.03 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T